Human monkeypox

Clinical Infectious Diseases

Volumn 58, Issue 2, 2014, Pages 260-267

  Wilson, Mary E ^a   Hughes, James M ^a   McCollum, Andrea M ^a   Damon, Inger K ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

Monkeypox; Orthopoxvirus; Smallpox

Indexed keywords

BRINCIDOFOVIR; CIDOFOVIR; IMMUNOGLOBULIN G; LC 16M 8; MONKEYPOX VACCINE; SMALLPOX VACCINE; TECOVIRIMAT; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ARTICLE; CENTRAL AFRICA; CERVICAL LYMPHADENOPATHY; CHICKENPOX; DEHYDRATION; DIFFERENTIAL DIAGNOSIS; DISEASE SURVEILLANCE; ECOLOGY; ELECTRON MICROSCOPY; ENCEPHALITIS; EYE INFECTION; FATIGUE; HEADACHE; HEALTH EDUCATION; HUMAN; IMMUNOHISTOCHEMISTRY; INCUBATION TIME; LYMPHADENOPATHY; MALAISE; MONKEYPOX; ORTHOPOXVIRUS; PRIORITY JOURNAL; RASH; REAL TIME POLYMERASE CHAIN REACTION; RURAL AREA; SEPTICEMIA; SMALLPOX; VIRUS CULTURE; VIRUS ISOLATION;

MONKEYPOX; ORTHOPOXVIRUS; SMALLPOX;

AFRICA, CENTRAL; ANIMALS; COMMUNICABLE DISEASES, EMERGING; ENDEMIC DISEASES; HUMANS; MONKEYPOX; ORTHOPOXVIRUS; RURAL POPULATION; ZOONOSES;

EID: 84891787107     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cit703     Document Type: Article

References (51)

1. Ladnyj ID, Ziegler P, Kima E. A human infection caused by monkeypox virus in Basankusu Territory, Democratic Republic of the Congo. Bull World Health Organ 1972; 46:593-7
2. Breman JG, Henderson DA. Diagnosis and management of smallpox. N Engl J Med 2002; 346:1300-8
3. Breman JG, Kalisa R, Steniowski MV, Zanotto E, Gromyko AI, Arita I. Human monkeypox, 1970-79. Bull World Health Organ 1980; 58: 165-82
4. Jezek Z, Fenner F. Human monkeypox. New York: Karger, 1988
5. Damon IK. Status of human monkeypox: Clinical disease, epidemiology and research. Vaccine 2011; 29(suppl 4): D54-9
6. Di Giulio DB, Eckburg PB. Human monkeypox: An emerging zoonosis. Lancet Infect Dis 2004; 4:15-25
7. Jezek Z, Szczeniowski M, Paluku KM, Mutombo M. Human monkeypox: Clinical features of 282 patients. J Infect Dis 1987; 156: 293-8
8. Learned LA, Reynolds MG, Wassa DW, et al. Extended interhuman transmission of monkeypox in a hospital community in the Republic of the Congo, 2003. Am J Trop Med Hyg 2005; 73:428-34
9. Macneil A, Reynolds MG, Braden Z, et al. Transmission of atypical varicella-zoster virus infections involving palm and sole manifestations in an area with monkeypox endemicity. Clin Infect Dis 2009; 48: E6-8
10. Seward JF, Galil K, Damon I, et al. Development and experience with an algorithm to evaluate suspected smallpox cases in the United States, 2002-2004. Clin Infect Dis 2004; 39:1477-83
11. Kulesh DA, Loveless BM, Norwood D, et al. Monkeypox virus detection in rodents using real-Time 3′-minor groove binder TaqMan assays on the Roche LightCycler. Lab Invest 2004; 84:1200-8
12. Li Y, Olson VA, Laue T, Laker MT, Damon IK. Detection of monkeypox virus with real-Time PCR assays. J Clin Virol 2006; 36:194-203
13. Olson VA, Laue T, Laker MT, et al. Real-Time PCR system for detection of orthopoxviruses and simultaneous identification of smallpox virus. J Clin Microbiol 2004; 42:1940-6
14. Shchelkunov SN, Shcherbakov DN, Maksyutov RA, Gavrilova EV. Species-specific identification of variola, monkeypox, cowpox, and vaccinia viruses by multiplex real-Time PCR assay. J Virol Methods 2011; 175:163-9
15. Karem KL, Reynolds M, Braden Z, et al. Characterization of acutephase humoral immunity to monkeypox: Use of immunoglobulin M enzyme-linked immunosorbent assay for detection of monkeypox infection during the 2003 North American outbreak. Clin Diagn Lab Immunol 2005; 12:867-72
16. Townsend MB, Macneil A, Reynolds MG, et al. Evaluation of the Tetracore Orthopox BioThreat® antigen detection assay using laboratory grown orthopoxviruses and rash illness clinical specimens. J Virol Methods 2013; 187:37-42
17. Reynolds MG, Damon IK. Outbreaks of human monkeypox after cessation of smallpox vaccination. Trends Microbiol 2012; 20:80-7
18. Formenty P, Muntasir MO, Damon I, et al. Human monkeypox outbreak caused by novel virus belonging to Congo Basin clade, Sudan, 2005. Emerg Infect Dis 2010; 16:1539-45
19. Berthet N, Nakoune E, Whist E, et al. Maculopapular lesions in the Central African Republic. Lancet 2011; 378:1354
20. Lash RR, Carroll DS, Hughes CM, et al. Effects of georeferencing effort on mapping monkeypox case distributions and transmission risk. Int J Health Geogr 2012; 11:23
21. Ellis CK, Carroll DS, Lash RR, et al. Ecology and geography of human monkeypox case occurrences across Africa. JWildl Dis 2012; 48:335-47
22. Reed KD, Melski JW, Graham MB, et al. The detection of monkeypox in humans in theWestern Hemisphere. N Engl JMed 2004; 350:342-50
23. Centers for Disease C, Prevention. Update: Multistate outbreak of monkeypox - Illinois, Indiana, Kansas, Missouri, Ohio, and Wisconsin, 2003. MMWR Morb Mortal Wkly Rep 2003; 52:642-6
24. Khodakevich L, Jezek Z, Kinzanzka K. Isolation of monkeypox virus from wild squirrel infected in nature. Lancet 1986; 1:98-9
25. Reynolds MG, Carroll DS, Karem KL. Factors affecting the likelihood of monkeypox's emergence and spread in the post-smallpox era. Curr Opin Virol 2012; 2:335-43
26. Hutson CL, Olson VA, Carroll DS, et al. A prairie dog animal model of systemic orthopoxvirus disease using West African and Congo Basin strains of monkeypox virus. J Gen Virol 2009; 90(Pt 2):323-33
27. Jezek Z, Grab B, Szczeniowski MV, Paluku KM, Mutombo M. Human monkeypox: Secondary attack rates. BullWorld Health Organ 1988; 66: 465-70
28. Fleischauer AT, Kile JC, Davidson M, et al. Evaluation of human-Tohuman transmission of monkeypox from infected patients to health care workers. Clin Infect Dis 2005; 40:689-94
29. Vaccinia (smallpox) vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP), 2001. MMWR Morb Mortal Wkly Rep 2001; 50(RR10):1-25
30. Fine PE, Jezek Z, Grab B, Dixon H. The transmission potential of monkeypox virus in human populations. Int J Epidemiol 1988; 17:643-50
31. Rimoin AW, Mulembakani PM, Johnston SC, et al. Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo. Proc Natl Acad Sci U S A 2010; 107:16262-7
32. Karem KL, Reynolds M, Hughes C, et al. Monkeypox-induced immunity and failure of childhood smallpox vaccination to provide complete protection. Clin Vaccine Immunol 2007; 14:1318-27
33. Likos AM, Sammons SA, Olson VA, et al. A tale of two clades: Monkeypox viruses. J Gen Virol 2005; 86(Pt 10):2661-72
34. Saijo M, Ami Y, Suzaki Y, et al. Virulence and pathophysiology of the Congo Basin and West African strains of monkeypox virus in nonhuman primates. J Gen Virol 2009; 90(Pt 9):2266-71
35. Reynolds MG, Yorita KL, Kuehnert MJ, et al. Clinical manifestations of human monkeypox influenced by route of infection. J Infect Dis 2006; 194:773-80
36. Hammarlund E, Dasgupta A, Pinilla C, Norori P, Fruh K, Slifka MK. Monkeypox virus evades antiviral CD4+ and CD8+ T cell responses by suppressing cognate T cell activation. Proc Natl Acad Sci U S A 2008; 105:14567-72
37. Estep RD, Messaoudi I, O'Connor MA, et al. Deletion of the monkeypox virus inhibitor of complement enzymes locus impacts the adaptive immune response to monkeypox virus in a nonhuman primate model of infection. J Virol 2011; 85:9527-42
38. Hudson PN, Self J, Weiss S, et al. Elucidating the role of the complement control protein in monkeypox pathogenicity. PLoS One 2012; 7: E35086
39. Kindrachuk J, Arsenault R, Kusalik A, et al. Systems kinomics demonstrates Congo Basin monkeypox virus infection selectively modulates host cell signaling responses as compared to West African monkeypox virus. Mol Cell Proteomics 2012; 11:M111 015701
40. Rubins KH, Hensley LE, Relman DA, Brown PO. Stunned silence: Gene expression programs in human cells infected with monkeypox or vaccinia virus. PLoS One 2011; 6:e15615
41. Parker S, Handley L, Buller RM. Therapeutic and prophylactic drugs to treat orthopoxvirus infections. Future Virol 2008; 3:595-612
42. Lederman ER, Davidson W, Groff HL, et al. Progressive vaccinia: Case description and laboratory-guided therapy with vaccinia immune globulin, ST-246, and CMX001. J Infect Dis 2012; 206:1372-85
43. Vora S, Damon I, Fulginiti V, et al. Severe eczema vaccinatum in a household contact of a smallpox vaccinee. Clin Infect Dis 2008; 46:1555-61
44. Earl PL, Americo JL, Wyatt LS, et al. Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox. Nature 2004; 428:182-5
45. Earl PL, Americo JL, Wyatt LS, et al. Rapid protection in a monkeypox model by a single injection of a replication-deficient vaccinia virus. Proc Natl Acad Sci U S A 2008; 105:10889-94
46. Stittelaar KJ, van Amerongen G, Kondova I, et al. Modified vaccinia virus Ankara protects macaques against respiratory challenge with monkeypox virus. J Virol 2005; 79:7845-51
47. Edghill-Smith Y, Bray M, Whitehouse CA, et al. Smallpox vaccine does not protect macaques with AIDS from a lethal monkeypox virus challenge. J Infect Dis 2005; 191:372-81
48. Saijo M, Ami Y, Suzaki Y, et al. LC16m8, a highly attenuated vaccinia virus vaccine lacking expression of the membrane protein B5R, protects monkeys from monkeypox. J Virol 2006; 80:5179-88
49. Kenner J, Cameron F, Empig C, Jobes DV, Gurwith M. LC16m8: An attenuated smallpox vaccine. Vaccine 2006; 24:7009-22
50. Reynolds MG, Emerson GL, Pukuta E, et al. Detection of human monkeypox in the Republic of the Congo following intensive community education. Am J Trop Med Hyg 2013; 88:982-5
51. Nakazawa Y, Emerson GL, Carroll DS, et al. Phylogenetic and ecologic perspectives of a monkeypox outbreak, southern Sudan, 2005. Emerg Infect Dis 2013; 19:237-45